22
Views
24
CrossRef citations to date
0
Altmetric
Research Article

p53 Expression in Correlation to Clinical Outcome in Patients with Renal Cell Carcinoma

Pages 15-20 | Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhong Jiang. (2007) Prognostic biomarkers in renal cell carcinoma. Expert Review of Molecular Diagnostics 7:3, pages 293-307.
Read now

Articles from other publishers (23)

Xiaohui Zhan, Yusong Liu, Christina Y. Yu, Tian-Fu Wang, Jie Zhang, Dong Ni & Kun Huang. (2020) A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma. BMC Medical Genomics 13:S11.
Crossref
Zhun Wang, Shuanghe Peng, Ning Jiang, Aixiang Wang, Shuguang Liu, Hui Xie, Linpei Guo, Qiliang Cai & Yuanjie Niu. (2017) Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis. Oncotarget 8:60, pages 102361-102370.
Crossref
Prajwal Dhakal, Smith Giri, Krishmita Siwakoti, Supratik Rayamajhi & Vijaya Raj Bhatt. (2016) Renal Cancer in Recipients of Kidney Transplant. Rare Tumors 9:1, pages 9-13.
Crossref
Jacqueline M. Speed, Quoc-Dien Trinh, Toni K. Choueiri & Maxine Sun. (2017) Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data. Current Urology Reports 18:2.
Crossref
Laura-Maria Krabbe, Vitaly Margulis & Yair Lotan. (2016) Prognostic Role of Cell Cycle and Proliferative Markers in Clear Cell Renal Cell Carcinoma. Urologic Clinics of North America 43:1, pages 105-118.
Crossref
Maryam Abolhasani, Sareh Salarinejad & Mojgan Asgari. (2015) P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy - Iranian Experience. Asian Pacific Journal of Cancer Prevention 16:12, pages 5043-5047.
Crossref
Ingrid Hodorova, Peter Solar, Jozef Mihalik, Janka Vecanova, Marian Adamkov & Silvia Rybarova. (2014) Investigation of tumour supressor protein p53 in renal cell carcinoma patients. Biomedical Papers 158:1, pages 044-049.
Crossref
K. Szymańska, L.E. Moore, N. Rothman, W.H. Chow, F. Waldman, E. Jaeger, T. Waterboer, L. Foretova, M. Navratilova, V. Janout, H. Kollarova, D. Zaridze, V. Matveev, D. Mates, N. Szeszenia-Dabrowska, I. Holcatova, V. Bencko, F. Le Calvez-Kelm, S. Villar, M. Pawlita, P. Boffetta, P. Hainaut & P. Brennan. (2010) TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe. Cancer Letters 293:1, pages 92-98.
Crossref
Aidan P. Noon, Nikolina Vlatković, Radosław Polański, Maria Maguire, Howida Shawki, Keith Parsons & Mark T. Boyd. (2010) p53 and MDM2 in renal cell carcinoma. Cancer 116:4, pages 780-790.
Crossref
Dragomir P. Zubac, Leif Bostad, Björn Kihl, Tomas Seidal, Tore Wentzel-Larsen & Svein A. Haukaas. (2009) The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival. Journal of Urology 182:5, pages 2144-2149.
Crossref
Hailiang Zhang, Dingwei Ye, Xudong Yao, Bo Dai, Shilin Zhang, Yijun Shen, Yao Zhu & Huirong Mao. (2008) Role of KIT expression in the prognosis of clear cell renal cell carcinomas in Chinese patients. Journal of Cancer Research and Clinical Oncology 135:2, pages 249-253.
Crossref
Anne Gentil Perret, Alix Clemencon, Guorong Li, Jacques Tostain & Michel Peoc’h. (2008) Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma. BJU International 102:2, pages 183-187.
Crossref
Jaiyeola O. Thomas & Ossama W. Tawfik. (2008) Recent advances in the diagnosis of renal cell carcinoma. Diagnostic Histopathology 14:4, pages 157-163.
Crossref
Ossama W. Tawfik, Brandan Kramer, Barbara Shideler, Marsha Danley, Bruce F. Kimler & Jeffrey Holzbeierlein. (2007) Prognostic Significance of CD44, Platelet-Derived Growth Factor Receptor α, and Cyclooxygenase 2 Expression in Renal Cell Carcinoma. Archives of Pathology & Laboratory Medicine 131:2, pages 261-267.
Crossref
A.E. Pinto, P. Monteiro, G. Silva, J.V. Ayres & J. Soares. (2018) Prognostic Biomarkers in Renal Cell Carcinoma: Relevance of DNA Ploidy in Predicting Disease-Related Survival. The International Journal of Biological Markers 20:4, pages 249-256.
Crossref
Brandon A. Kramer, Xin Gao, Marilyn Davis, Matt Hall, Jeffrey Holzbeierlein & Ossama Tawfik. (2005) Prognostic Significance of Ploidy, MIB-1 Proliferation Marker, and p53 in Renal Cell Carcinoma. Journal of the American College of Surgeons 201:4, pages 565-570.
Crossref
. 2005. The Sentinel Lymph Node Concept. The Sentinel Lymph Node Concept 481 497 .
Andrea Vecchione, Tommaso Prayer Galetti, Marina Gardiman, Hideshi Ishii, Enrico Giarnieri, Francesco Pagano, Leonard G Gomella, Carlo M Croce & Raffaele Baffa. (2004) Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases. BMC Urology 4:1.
Crossref
B. Ljungberg. (2016) Prognostic Factors in Renal Cell Carcinoma. Scandinavian Journal of Surgery 93:2, pages 118-125.
Crossref
Richard Zigeuner, Manfred Ratschek, Peter Rehak, Luigi Schips & Cord Langner. (2004) Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue. Urology 63:4, pages 651-655.
Crossref
D. Sánchez Zalabardo, J. Arocena García-Tapia, J.M. Regojo Balboa, J.M. Fernández Montero, J. López Ferrandis, D. Rosell Costa, J.E. Robles García, J.J. Zudaire Bergera & J.M. Berían Polo. (2003) Factores pronóstico en carcinoma renal pt3. Actas Urológicas Españolas 27:1, pages 26-32.
Crossref
D. Sánchez Zalabardo, J. López Ferrandis, J. Arocena García-Tapia, J.Mª Rogojo Balboa, J.M. Fernández Montero, D. Rosell Costa, J.E. Robles García, J.J. Zudaire Bergera & J.Mª Berián Polo. (2002) Clínica, diagnóstico y pronóstico del carcinoma renal. Actas Urológicas Españolas 26:8, pages 532-540.
Crossref
John L. Phillips, Christian P. Pavlovich, McClellan Walther, Thomas Ried & W. Marston Linehan. (2001) The genetic basis of renal epithelial tumors: advances in research and its impact on prognosis and therapy. Current Opinion in Urology 11:5, pages 463-469.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.